Last reviewed · How we verify

NCT03938220

Electrical Cardiometry Compared to Transthoracic Echocardiography in Fluid Responsiveness in Sepsis

Completed Last updated 3 May 2022
What this trial tests

trial testing Electrical Cardiometry in Electrical Cardiometry in 25 participants. Completed in 10 September 2021.

Timeline
1 June 2019
Primary endpoint
10 September 2021
10 September 2021

Quick facts

Lead sponsorTanta University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment25
Start date1 June 2019
Primary completion10 September 2021
Estimated completion10 September 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 19 to 65, any sex, with Electrical Cardiometry or Transthoracic Echocardiography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the diagnostic accuracy of electrical cardiometry (EC) for the noninvasive determination of fluid responsiveness in sepsis and agreement of (EC) compared to transthoracic echocardiography (TTE).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Electrical Cardiometry

Trials testing the same drug.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03938220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing